Stopping Alzheimer's Disease and Related Dementias: Advancing Our Nation's Research Agenda
About the FY 2018 Bypass Budget
With the 2011 National Alzheimer's Project Act, research aimed at a cure for Alzheimer's disease and related dementias became a national priority, and a National Plan to Address Alzheimer's Disease was established. At the direction of Congress, the National Institutes of Health (NIH) develops an annual professional judgment budget to estimate the funds needed to fully pursue scientific opportunities to meet the research goal of the Plan—to effectively treat and prevent Alzheimer's and related dementias by 2025. Biomedical studies and care and services research are addressed in the budget estimate.
The professional judgment budget is also called a "bypass budget" because it is submitted to the President and then to Congress, without modification through the traditional Federal budget process. It includes a set of targeted milestones and an estimate of the additional investment needed in fiscal year (FY) 2018, above the base for Alzheimer's and related dementias in the President's FY 2017 budget to help NIH—and the Nation—move forward to end the devastation of dementia. The bypass budget also highlights recent NIH-supported basic, translational, and clinical research—a wealth of studies that are helping us better understand, diagnose, prevent, and treat Alzheimer's and related dementias.
The NIH FY 2018 Bypass Budget for Alzheimer's Disease and Related Dementias was presented August 1, 2016.
Here you will find:
This executive summary outlines the toll Alzheimer's takes on the United States and promising opportunities in Alzheimer's and related dementia research that NIH is pursuing.
Use this database to explore the full set of Alzheimer's-related research implementation milestones, through 2025. Search by year, research implementation areas, and CADRO category.
Publication Date: July 2016
Page Last Updated: August 15, 2016